Cargando…
Incidence of anti-platelet factor4/polyanionic antibodies, thrombocytopenia, and thrombosis after COVID-19 vaccination with ChAdOx1 nCoV-19 in Thais
BACKGROUND: The prevalence of anti-platelet factor 4 (PF4)/polyanionic antibodies occurring after vaccination with ChAdOx1 nCoV-19 is low. Most of these antibodies are not associated with vaccine-induced thrombotic thrombocytopenia. It remains unknown whether these antibodies are preexisting or occu...
Autores principales: | Boonyawat, Kochawan, Phojanasenee, Tichayapa, Noikongdee, Phichchapha, Police, Pornnapa, Chantrathammachart, Pichika, Niparuck, Pimjai, Puavilai, Teeraya, Phuphuakrat, Angsana, Angchaisuksiri, Pantep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481453/ https://www.ncbi.nlm.nih.gov/pubmed/37674185 http://dx.doi.org/10.1186/s12959-023-00533-z |
Ejemplares similares
-
Prevalence of anti–platelet factor 4/polyanionic antibodies after COVID‐19 vaccination with ChAdOx1 nCoV‐19 and CoronaVac in Thais
por: Noikongdee, Phichchapha, et al.
Publicado: (2021) -
Correction to: Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis
por: Boonyawat, Kochawan, et al.
Publicado: (2020) -
Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis
por: Boonyawat, Kochawan, et al.
Publicado: (2020) -
Treatment outcome and prognostic factors in PCNSL
por: Niparuck, Pimjai, et al.
Publicado: (2019) -
Cytogenetics and FLT3-ITD mutation predict clinical outcomes in non transplant patients with acute myeloid leukemia
por: Niparuck, Pimjai, et al.
Publicado: (2019)